n-(mercaptoacetyl)glycine has been researched along with Coronary Restenosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hong, MK; Lee, HK; Lee, WW; Moon, DH; Oh, SJ; Park, SJ; Park, SW; Shin, DI | 1 |
Hong, MK; Jang, JS; Jeong, YH; Kim, JJ; Kim, SH; Kim, YH; Lee, CW; Lee, SW; Park, DW; Park, SJ; Park, SW; Yun, SC | 1 |
2 other study(ies) available for n-(mercaptoacetyl)glycine and Coronary Restenosis
Article | Year |
---|---|
Automated preparation of 188Re-labeled radiopharmaceuticals for endovascular radiation therapy.
Topics: Brachytherapy; Computer Systems; Computing Methodologies; Coronary Restenosis; Equipment Design; Equipment Failure Analysis; Glycine; Humans; Isotope Labeling; Pentetic Acid; Radioisotopes; Radiopharmaceuticals; Rhenium; Robotics; Systems Integration; Vascular Diseases | 2003 |
Comparison of six-month angiographic and three-year outcomes after sirolimus-eluting stent implantation versus brachytherapy for bare metal in-stent restenosis.
Topics: Brachytherapy; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Female; Glycine; Humans; Male; Middle Aged; Radioisotopes; Radiotherapy Dosage; Rhenium; Sirolimus; Stents; Treatment Outcome | 2007 |